PDS Biotech Shows Promising Phase 2 Results in Late-Line Prostate Cancer—Median PFS Reaches 9.6 Months
Market Chameleon (Wed, 28-Jan 10:34 AM)
FDA Alignment on Progression-Free Survival Paves Potential Accelerated Path for PDSB’s Lead Immunotherapy
Market Chameleon (Fri, 9-Jan 10:32 AM)
PDS Biotech Expands Global Patent Protection for PDS0101 with Key Grant in Japan
Market Chameleon (Tue, 9-Dec 11:08 AM)
PDS Biotechnology Showcases Robust Clinical and Immunological Responses With PDS0101 and PDS01ADC in New SITC 2025 Data
Market Chameleon (Mon, 10-Nov 11:20 AM)
